These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 35318713)
1. Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data. Roussin A; Soeiro T; Fouque C; Jouanjus E; Frauger E; Fouilhé N; Mallaret M; Micallef J; Lapeyre-Mestre M; Br J Clin Pharmacol; 2022 Aug; 88(8):3789-3802. PubMed ID: 35318713 [TBL] [Abstract][Full Text] [Related]
2. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance. Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M; Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345 [No Abstract] [Full Text] [Related]
3. Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020. Diaz L; Eiden C; Jouanjus E; Frauger E; Fouilhé N; Djezzar S; Gibaja V; Boucher A; Le Boisselier R; Libert F; Caous AS; Monzon E; Guerlais M; Daveluy A; Fauconneau B; Peyrière H Therapie; 2023; 78(6):647-657. PubMed ID: 36918317 [TBL] [Abstract][Full Text] [Related]
4. [Surveillance system on drug abuse: Interest of the French national OPPIDUM program of French addictovigilance network]. Frauger E; Pochard L; Boucherie Q; Giocanti A; Chevallier C; Daveluy A; Gibaja V; Caous AS; Eiden C; Authier N; Le Boisselier R; Guerlais M; Jouanjus É; Lepelley M; Pizzoglio V; Pain S; Richard N; Micallef J; Therapie; 2017 Sep; 72(4):491-501. PubMed ID: 28343650 [TBL] [Abstract][Full Text] [Related]
5. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health]. Micallef J; Jouanjus É; Mallaret M; Lapeyre Mestre M Therapie; 2019 Dec; 74(6):579-590. PubMed ID: 31694770 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of abuse and dependence in addiction monitoring systems: tramadol as an example. Roussin A; Doazan-d'Ouince O; Géniaux H; Halberer C; Therapie; 2015; 70(2):203-21. PubMed ID: 25858577 [TBL] [Abstract][Full Text] [Related]
7. Addictovigilance contribution during COVID-19 epidemic and lockdown in France. Lapeyre-Mestre M; Boucher A; Daveluy A; Gibaja V; Jouanjus E; Mallaret M; Peyrière H; Micallef J; Therapie; 2020; 75(4):343-354. PubMed ID: 32660776 [TBL] [Abstract][Full Text] [Related]
8. Trends in fatal poisoning among medical users of analgesics in France from 2013 to 2022: an analysis of the DTA register. Revol B; Willeman T; Manceau M; Dumestre-Toulet V; Gaulier JM; Eysseric-Guérin H; Fouilhé Sam-Laï N; Public Health; 2024 Nov; 236():381-385. PubMed ID: 39303626 [TBL] [Abstract][Full Text] [Related]
9. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany. Radbruch L; Glaeske G; Grond S; Münchberg F; Scherbaum N; Storz E; Tholen K; Zagermann-Muncke P; Zieglgänsberger W; Hoffmann-Menzel H; Greve H; Cremer-Schaeffer P Subst Abus; 2013; 34(3):313-20. PubMed ID: 23844964 [TBL] [Abstract][Full Text] [Related]
10. Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey. Blayac L; Ponte C; Lavaud M; Micallef J; Lapeyre-Mestre M Therapie; 2023; 78(2):201-211. PubMed ID: 36283856 [TBL] [Abstract][Full Text] [Related]
11. Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network. Gandolfo P; Soeiro T; Jouve É; Revol B; Daveluy A; Bertin C; Eiden C; Gibaja V; Chaouachi L; Pérault-Pochat MC; Chevallier C; Aquizérate A; Le Boisselier R; Carton L; Lapeyre-Mestre M; Frauger É; Lacroix C; Micallef J Fundam Clin Pharmacol; 2024 Oct; 38(5):978-987. PubMed ID: 38372190 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. Adams EH; Breiner S; Cicero TJ; Geller A; Inciardi JA; Schnoll SH; Senay EC; Woody GE J Pain Symptom Manage; 2006 May; 31(5):465-76. PubMed ID: 16716877 [TBL] [Abstract][Full Text] [Related]
13. Health consequences of cocaine use in France: data from the French Addictovigilance Network. Eiden C; Vincent M; Serrand C; Serre A; Richard N; Picot MC; Frauger E; Fouilhé N; Daveluy A; Peyrière H; Fundam Clin Pharmacol; 2021 Apr; 35(2):455-465. PubMed ID: 32854152 [TBL] [Abstract][Full Text] [Related]
14. Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey. Boeuf O; Lapeyre-Mestre M; Drug Saf; 2007; 30(3):265-76. PubMed ID: 17343432 [TBL] [Abstract][Full Text] [Related]
15. [Treatment with tramadol can give rise to dependence and abuse]. Näslund S; Dahlqvist R Lakartidningen; 2003 Feb; 100(9):712-4. PubMed ID: 12674559 [TBL] [Abstract][Full Text] [Related]
16. Ten-year trend of opioid and nonopioid analgesic use in the French adult population. Daveluy A; Micallef J; Sanchez-Pena P; Miremont-Salamé G; Lassalle R; Lacueille C; Grelaud A; Corand V; Victorri-Vigneau C; Batisse A; Le Boisselier R; Peyrière H; Frauger E; Lapeyre-Mestre M; Haramburu F Br J Clin Pharmacol; 2021 Feb; 87(2):555-564. PubMed ID: 32496599 [TBL] [Abstract][Full Text] [Related]
17. The investigation of tramadol dependence with no history of substance abuse: a cross-sectional survey of spontaneously reported cases in Guangzhou City, China. Zhang H; Liu Z Biomed Res Int; 2013; 2013():283425. PubMed ID: 24151592 [TBL] [Abstract][Full Text] [Related]
18. Use of new psychoactive substances to mimic prescription drugs: The trend in France. Batisse A; Eiden C; Peyriere H; Djezzar S; Neurotoxicology; 2020 Jul; 79():20-24. PubMed ID: 32240674 [TBL] [Abstract][Full Text] [Related]
19. Association of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Clinical Outcomes. Xie J; Strauss VY; Martinez-Laguna D; Carbonell-Abella C; Diez-Perez A; Nogues X; Collins GS; Khalid S; Delmestri A; Turkiewicz A; Englund M; Tadrous M; Reyes C; Prieto-Alhambra D JAMA; 2021 Oct; 326(15):1504-1515. PubMed ID: 34665205 [TBL] [Abstract][Full Text] [Related]
20. Effect of the market withdrawal of dextropropoxyphene on use of other prescribed analgesics. Reset A; Skurtveit S; Furu K; Skovlund E Scand J Pain; 2018 Oct; 18(4):667-674. PubMed ID: 30145581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]